                            VULPES CELARE
                         Evaluation License
                      Version 1.1, December 2025

    Copyright (c) 2025 Vulpes Celare Contributors
                    All Rights Reserved


========================================================================
                        SOURCE-AVAILABLE SOFTWARE
           Commercial licensing and partnerships are welcome.
========================================================================


TERMS AND CONDITIONS


1. DEFINITIONS

   "Software" means the Vulpes Celare source code, documentation,
   binaries, and all associated files in this repository.

   "You" means the individual or entity exercising rights under
   this License.

   "Clinical Use" means any use involving real patient data, live
   healthcare workflows, or deployment in medical settings.

   "Commercial Use" means any use intended for or directed toward
   commercial advantage or monetary compensation.


2. GRANT OF LIMITED RIGHTS

   Subject to the terms of this License, the copyright holders grant
   You a limited, non-exclusive, non-transferable, revocable right to:

     (a) View, read, and study the source code;
     (b) Run the Software locally for evaluation and testing;
     (c) Benchmark and assess performance characteristics;
     (d) Conduct security reviews and code audits;
     (e) Use the Software for non-commercial academic research;
     (f) Use the Software for personal learning and education;
     (g) Create internal proof-of-concept demonstrations;
     (h) Cite the Software in academic publications.


3. USES REQUIRING A COMMERCIAL LICENSE

   The following uses require a separate commercial license agreement:

     (a) Use in any clinical or healthcare setting;
     (b) Processing of real patient data;
     (c) Deployment in any production environment;
     (d) Any Commercial Use;
     (e) Redistribution of the Software, in whole or in part;
     (f) Creation of derivative works for distribution;
     (g) Incorporation of the Software into other products;
     (h) Offering the Software as a hosted or managed service.

   These uses are available under a separate commercial agreement.
   See the "Commercial Licensing" section below.


4. ATTRIBUTION

   You may not remove or alter any license notices or attributions
   contained in the Software.


5. CLINICAL DISCLAIMER

   THIS SOFTWARE HAS NOT BEEN VALIDATED FOR CLINICAL USE.

   This Software has not been cleared, approved, or certified by any
   regulatory body including, but not limited to, the U.S. Food and
   Drug Administration (FDA), European Medicines Agency (EMA), or any
   CE marking authority.

   Use of this Software in clinical settings without appropriate
   licensing, validation, and regulatory clearance may result in
   patient harm. You assume all risk and liability for any such use.


6. NO WARRANTY

   THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND,
   EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES
   OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND
   NONINFRINGEMENT.

   IN NO EVENT SHALL THE COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM,
   DAMAGES, OR OTHER LIABILITY, WHETHER IN AN ACTION OF CONTRACT,
   TORT, OR OTHERWISE, ARISING FROM, OUT OF, OR IN CONNECTION WITH
   THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE SOFTWARE.


7. TERMINATION

   This License is effective until terminated. Your rights under this
   License will terminate automatically without notice if You fail to
   comply with any of its terms. Upon termination, You must destroy
   all copies of the Software in Your possession.


8. GOVERNING LAW

   This License shall be governed by and construed in accordance with
   the laws of the jurisdiction in which the primary copyright holder
   resides, without regard to conflict of law principles.


========================================================================
                         COMMERCIAL LICENSING
========================================================================

Commercial licensing, enterprise deployment, acquisition, and strategic
partnerships are explicitly welcomed.

Available licensing structures include:

    - Standalone commercial licenses
    - Dual-license models
    - OEM and embedded agreements
    - Enterprise site licenses
    - Strategic IP arrangements

Initial discussions are lightweight and exploratory. Licensing terms
are handled collaboratively as part of standard commercial discussions.

Where applicable, licensing terms may be coordinated with standard
institutional IP processes; this is handled collaboratively during
the commercial discussion.

For inquiries:

    Email:    andrew@vulpescelare.com
    GitHub:   https://github.com/DocHatty/Vulpes-Celare/issues
              (public or private issues welcome)

Email or open an issue to discuss evaluation, pilots, or potential commercial terms (subject to rights clearance).

========================================================================
